Laura B Kozell, Amy J Eshleman, Tracy L Swanson, Shelley H Bloom, Katherine M Wolfrum, Jennifer L Schmachtenberg, Randall J Olson, Aaron J Janowsky, Atheir I Abbas
Novel psychoactive substances, including synthetic substituted tryptamines, represent a potential public health threat. Additionally, some substituted tryptamines are being studied, under medical guidance, as potential treatments of psychiatric disorders. Characterizing the basic pharmacology of substituted tryptamines will aid in understanding differences in potential for harm or therapeutic use. Using HEK cells stably expressing 5-HT1A , 5-HT2A , and 5-HT2C receptors (5-HT1A R, 5-HT2A R, 5HT2C R respectively) or the serotonin transporter (SERT), we measured affinities, potencies and efficacies of 21 substituted tryptamines...
January 20, 2023: Journal of Pharmacology and Experimental Therapeutics